Loprox

Loprox is a brand name of ciclopirox topical, approved by the FDA in the following formulation(s):

LOPROX (ciclopirox - cream; topical)

• 
  Manufacturer: MEDICIS
  
  Approval date: December 30, 1982
  
  Strength(s): 0.77% ^[RLD][AB]

LOPROX (ciclopirox - gel; topical)

• 
  Manufacturer: MEDICIS
  
  Approval date: July 21, 1997
  
  Strength(s): 0.77% ^[RLD][AB]

LOPROX (ciclopirox - shampoo; topical)

• 
  Manufacturer: MEDICIS
  
  Approval date: February 28, 2003
  
  Strength(s): 1% ^[RLD][AT]

LOPROX (ciclopirox - suspension; topical)

• 
  Manufacturer: MEDICIS
  
  Approval date: December 30, 1988
  
  Strength(s): 0.77% ^[RLD][AB]

Has a generic version of Loprox been approved?

A generic version of Loprox has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Loprox and have been approved by the FDA:

ciclopirox cream; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: December 29, 2004
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: G AND W LABS INC
  
  Approval date: December 20, 2010
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: GLENMARK PHARMS
  
  Approval date: November 10, 2009
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: PERRIGO
  
  Approval date: March 3, 2006
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: April 12, 2005
  
  Strength(s): 0.77% ^[AB]

ciclopirox gel; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: June 10, 2008
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: PADDOCK LLC
  
  Approval date: January 7, 2009
  
  Strength(s): 0.77% ^[AB]

ciclopirox shampoo; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: May 25, 2010
  
  Strength(s): 1% ^[AT]


• 
  Manufacturer: PADDOCK LLC
  
  Approval date: November 24, 2009
  
  Strength(s): 1% ^[AT]


• 
  Manufacturer: PERRIGO
  
  Approval date: February 16, 2010
  
  Strength(s): 1% ^[AT]


• 
  Manufacturer: TARO
  
  Approval date: February 23, 2011
  
  Strength(s): 1% ^[AT]

ciclopirox suspension; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: August 6, 2004
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: PERRIGO NEW YORK
  
  Approval date: December 15, 2006
  
  Strength(s): 0.77% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: August 10, 2005
  
  Strength(s): 0.77% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Loprox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Antimycotic gel with high active substance release
  Patent 7,018,656
  Issued: March 28, 2006
  Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
  Assignee(s): Aventis Pharma Deutschland GmbH
  A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
  
  Patent expiration dates:
  
  
  • September 5, 2018
    
    ✓ 
    Drug product
  
  



• 
  Antimycotic gel having high active compound release
  Patent 7,026,337
  Issued: April 11, 2006
  Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
  Assignee(s): Aventis Pharma Deutschland GmbH
  A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
  
  Patent expiration dates:
  
  
  • November 21, 2016
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM
  
  



• 
  Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
  Patent 7,981,909
  Issued: July 19, 2011
  Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
  Assignee(s): Medicis Pharmaceutical Corporation
  Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
  
  Patent expiration dates:
  
  
  • September 16, 2017
    
    ✓ 
    Patent use: TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP
  
  

See also...

• Loprox Cream Consumer Information (Wolters Kluwer)
• Loprox Gel Consumer Information (Wolters Kluwer)
• Loprox Shampoo Consumer Information (Wolters Kluwer)
• Loprox Suspension Consumer Information (Wolters Kluwer)
• Loprox Consumer Information (Cerner Multum)
• Loprox Topical Advanced Consumer Information (Micromedex)
• Ciclopirox Cream Consumer Information (Wolters Kluwer)
• Ciclopirox Gel Consumer Information (Wolters Kluwer)
• Ciclopirox Shampoo Consumer Information (Wolters Kluwer)
• Ciclopirox Solution Consumer Information (Wolters Kluwer)
• Ciclopirox Solution Kit Consumer Information (Wolters Kluwer)
• Ciclopirox Suspension Consumer Information (Wolters Kluwer)
• Ciclopirox topical Consumer Information (Cerner Multum)
• Ciclopirox Topical Advanced Consumer Information (Micromedex)
• Ciclopirox Olamine AHFS DI Monographs (ASHP)